Teladoc Faces Securities Investigation Following Revenue Guidance Cut

The inquiry centers on whether Teladoc and its leadership engaged in securities fraud or unlawful business practices leading up to the company’s July 29, 2026, financial disclosure. During that update, the firm slashed its full-year 2026 revenue guidance to a range of $2.36 billion to $2.45 billion, down from previous projections of up to $2.58 billion. Leadership attributed the downward revision to uncertainties surrounding cash-pay revenue and structural difficulties within the BetterHelp segment, specifically citing lagging network capacity and a sharp decline in cash-paying users.

Investors responded aggressively to the news, driving the stock price down by $2.60 to close at $6.58 on July 30. Pomerantz LLP, a firm specializing in securities and corporate litigation, is now soliciting contact from shareholders affected by the decline. The investigation aims to determine if management failed to disclose material risks to the company's business model before the guidance adjustment.